On Sept.17, the United States District Court for the Eastern District of Pennsylvania determined a blind man didn’t provide enough evidence that Sam’s Oyster House discriminated against him through its website.
U.S. District Court for the Eastern District of Pennsylvania News
PHILADELPHIA (Legal Newsline) — Defendants AbbVie Inc., Abbott Laboratories and Unimed Pharmaceuticals LLC filed an appeal on Aug. 6 in a U.S. District Court in response to the final judgment in an antitrust case that found in favor of the Federal Trade Commission.
PHILADELPHIA - A federal judge has granted a motion made by the attorneys general for 44 states, including Pennsylvania, as well as the District of Columbia and Puerto Rico for a separate government track in a multidistrict antitrust case involving the pricing of generic pharmaceuticals.
Plaintiffs firm represented whistleblower in secret to avoid paying referral fee from multimillion-dollar case, lawsuit claims
PHILADELPHIA – A Texas personal injury law firm claims it is owed part of $16 million awarded to a corporate whistleblower because colleagues effectively poached the client and represented him in secret.
PHILADELPHIA – A ruling from a federal judge in Pennsylvania remains pending on whether or not compulsory arbitration will be permanently prohibited, in the case of a litigation funder that pursued financial recovery against a former National Football League player who allegedly failed to repay it a loan.
PHILADELPHIA (Legal Newsline) – Two animal advocacy organizations are seeking to compel a federal agency to propose rules that govern the handling, care and treatment of birds.
NFL alleges widespread fraud by unnamed plaintiffs lawyers, doctors in concussion settlement; Special investigator appropriate, class counsel says
PHILADELPHIA – If the National Football League has their way, sanctions will be issued and a special investigator will be appointed to the NFL’s $1 billion Concussion Settlement program, as the league alleges an independent claims administrator determined that 23 percent of the claims submitted to it were fraudulent.
PHILADELPHIA – The disagreement over funding by third parties continues to play out in an exchange between Pennsylvania and New York federal courts, as one such company defends itself from New York Attorney General Eric Schneiderman and the Consumer Financial Protection Bureau.
WASHINGTON (Legal Newsline) — The Federal Trade Commission (FTC) announced Jan. 10 that the assets of the operators of an alleged tech scam will be used to reimburse consumers victimized by the scheme.
Pfizer’s lawsuit, filed in a Pennsylvania federal court in September, alleges Johnson & Johnson’s exclusionary contracts and other anti-competitive practices have denied U.S. patients access to therapeutic options and undermined the benefits of “robust” price competition in the “innovative and growing” biologics marketplace for patients.
Stockholders of a Canadian company are suing operators of a Pennsylvania lending firm, alleging fraud and unjust enrichment involving a real estate loan.
A question in a lawsuit against a legal funding company that allegedly scammed 9/11 responders and former NFL players has swapped judges’ hands.
PHILADELPHIA (Legal Newsline) -- A public stockholder is suing a a corporation and its board of directors, alleging negligent misrepresentation and violation of federal securities law.
The six-member U.S. Judicial Panel on Multidistrict Litigation selected the U.S. District Court for the Eastern District of Pennsylvania to handle the lawsuits against defendants Allergan, Impax Laboratories, The Lannett Company, Mylan, Par Pharmaceuticals and West-Ward. Providence's class action against the drug manufacturers are among the cases being consolidated.